Molecular Mechanisms Underlying Antimicrobial Resistance in Klebsiella pneumoniae: Current Challenges and Emerging Therapeutic Interventions

Abstract

Antimicrobial resistance (AMR) has arisen as a paramount worldwide public health challenge of the twenty-first century, with Klebsiella pneumoniae identified as a key priority pathogen by the World Health Organization. This opportunistic Gram-negative bacterium causes several healthcare-associated and community-acquired illnesses, such as pneumonia, urinary tract infections, bloodstream infections, liver abscesses, and sepsis. The swift emergence and spread of multidrug-resistant (MDR), extensively drug-resistant (XDR), and carbapenem-resistant K. pneumoniae (CRKP) strains have significantly diminished the efficacy of traditional antimicrobial treatments, leading to heightened morbidity, mortality, extended hospital stays, and increased healthcare expenditures globally. The exceptional adaptability of K. pneumoniae is due to various resistance mechanisms, such as the synthesis of extended-spectrum βlactamases (ESBLs) and carbapenemases, biofilm formation, overexpression of efflux pumps, enzymatic alteration of antibiotics, diminished membrane permeability, and horizontal gene transfer via mobile genetic elements. This review thoroughly analyzes the present state of antibiotic resistance in K. pneumoniae, emphasizing the molecular and genetic processes behind its resistance phenotype and global epidemiological patterns. The review additionally addresses current therapeutic problems and assesses novel techniques designed to alleviate K. pneumoniae infections. These efforts encompass the creation of innovative antibiotics, antimicrobial peptides, bacteriophage therapy, immunotherapeutic methods, nanoparticle-based antimicrobial systems, CRISPR-Cas gene-editing technologies, anti-biofilm agents, and antimicrobial stewardship initiatives. The amalgamation of novel therapeutic strategies with efficient infection prevention, surveillance, and antibiotic stewardship initiatives may yield enduring solutions to mitigate the proliferation of resistant K. pneumoniae strains. Ongoing research and interdisciplinary collaboration are crucial for devising effective strategies to address this progressively resistant pathogen and mitigate the worldwide impact of antimicrobial resistance (AMR).